Search results for "Retinal"

showing 10 items of 631 documents

Association between the retinal vascular network, cardiovascular history and risk factors in the elderly

2017

IF 3.157; International audience; PurposeTo identify patterns summarizing the retinal vascular network in the elderly and to investigate the relationship of these vascular patterns with cardiovascular history.MethodsWe conducted a population-based study, the Montrachet study (Maculopathy Optic Nerve nuTRition neurovAsCular and HEarT diseases), in participants older than 75 years. History of cardiovascular disease and a score-based estimation of their 10-year risk of cardiovascular mortality (Heart SCORE) were collected. Retinal vascular network analysis was performed by means of Singapore “I” Vessel Assessment (SIVA) software. Principal component analysis was used to condense the informatio…

medicine.medical_specialtyPopulationprofile for cardiovascular mortality riskDiseasechemistry.chemical_compoundInternal medicineMedicine[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organseducationeducation.field_of_study[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyCardiovascular Historybusiness.industryRetinalGeneral MedicineOdds ratioNeurovascular bundlemedicine.disease3. Good healthSurgeryOphthalmologychemistry[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansCardiologyOptic nerveMaculopathybusinessRetinal vascular network[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Recent advances and disputes about curcumin in retinal diseases

2021

Abstract Curcumin belongs to the group of so-called phytocompounds, biologically active molecules produced by plants exerting a beneficial effect on health. Curcumin shows a wide spectrum of different properties, being an anti-inflammatory, antioxidant, antimicrobial and antimutagenic molecule. The purpose of the review is to examine what literature reported on the characteristics of curcumin, particularly, on the beneficial and controversial aspects of this molecule, aiming for a better therapeutic management of retinal diseases. The retina is a constant target of oxidative stress, this tissue being characterized by cells rich in mitochondria and by vessels and being, obviously, continuous…

medicine.medical_specialtyProliferative vitreoretinopathyantioxidant proprietiesReviewexosomesPharmacologymedicine.disease_causeRetinal ganglionanti-inflammatory proprieties; antioxidant proprieties; exosomes; miRNA; nanosphere; natural compounds03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOphthalmologymedicinenatural compoundsanti-inflammatory proprietiesmiRNARetinabusiness.industryRetinalDiabetic retinopathyMacular degenerationmedicine.diseasenanosphereOphthalmologymedicine.anatomical_structurechemistry030221 ophthalmology & optometryCurcuminbusiness030217 neurology & neurosurgeryOxidative stress
researchProduct

Variations of OCT measurements corrected for the magnification effect according to axial length and refractive error in children

2018

Purpose: The aim of this paper was to examine the distribution of macular, retinal nerve fiber layer (RNFL) thickness and optic disc parameters of myopic and hyperopic eyes in comparison with emmetropic control eyes and to investigate their variation according to axial length (AL) and spherical equivalent (SE) in healthy children. Methods: This study included 293 pairs of eyes of 293 children (145 boys and 148 girls), ranging in age from 6 to 17 years. Subjects were divided according to SE in control (emmetropia, 99 children), myopia (100 children) and hyperopia (94 children) groups and according to axial AL in 68 short ([Formula: see text]22.00[Formula: see text]mm, 68), medium (from [For…

medicine.medical_specialtyRefractive errorgenetic structuresmagnification effectBiomedical EngineeringNerve fiber layerMedicine (miscellaneous)MagnificationEmmetropiaUlls -- Acomodació i refraccióSpherical equivalent:Ciències de la visió::Optometria::Acomodació i refracció [Àrees temàtiques de la UPC]lcsh:TechnologyEye--Accommodation and refractionLength measurement03 medical and health sciencesAxial length0302 clinical medicinechildrenOphthalmologyDegeneració retinalmedicinelcsh:QC350-467refractive errorRetinal degenerationOptical coherence tomographybusiness.industrylcsh:TMean ageAxial lengthmedicine.diseaseAtomic and Molecular Physics and Opticseye diseasesElectronic Optical and Magnetic Materialsmedicine.anatomical_structureCoherència (Òptica)OCT measurements030221 ophthalmology & optometryOptometrysense organsbusinessInfants030217 neurology & neurosurgerylcsh:Optics. LightOptic disc
researchProduct

Arteriovenöse Dissektion (AVD) bei retinalen Venolenastverschlüssen

2009

BACKGROUND: The aim of this study is to report on arteriovenous sheathotomy in branch retinal vein occlusion (BRVO) with a long-term follow-up and examine the visual field effects of this surgical approach. PATIENTS AND METHODS: In a clinical trial 36 eyes with branch retinal vein occlusion (22 eyes with ischaemia, 14 eyes with chronic macular oedema) underwent surgical decompression accompanied by peeling of the membrana limitans interna after prior isovolemic haemodilution for 3 months had been unsuccessfull. RESULTS: All eyes showed a significant reduction of macular oedema 3 months after surgery. During follow-up (median: 26.4 months) visual acuity increased in 24 / 36 eyes and was stab…

medicine.medical_specialtyRetinaVisual acuitygenetic structuresDecompressionbusiness.industrymedicine.diseaseeye diseasesSurgeryVisual fieldOphthalmologymedicine.anatomical_structuremedicineBranch retinal vein occlusionsense organsmedicine.symptombusinessVitreous baseRetinal holeOptic discKlinische Monatsblätter für Augenheilkunde
researchProduct

Síndrome de Susac de presentación ocular atípica

2007

espanolCaso clinico: Mujer de 25 anos de edad afecta de encefalopatia y perdida auditiva neurosensorial, remitida a nuestro servicio para confirmar un sindrome de Susac por presentar una disminucion de agudeza visual bilateral. En la exploracion funduscopica se aprecio una microangiopatia retiniana periferica. Discusion: El sindrome de Susac se caracteriza tipicamente por la triada encefalopatia, perdida auditiva neurosensorial, y oclusiones de ramas arteriales retinianas. En nuestro caso las alteraciones oculares eran atipicas, apreciandose amputacion de vasos terminales con cumulo de microaneurismas en retina periferica de ambos ojos. EnglishCase report: A 25-year-old woman with encephalo…

medicine.medical_specialtyRetinal Artery Occlusionbusiness.industryHearing lossEncephalopathyPeripheral retinapérdida auditivamedicine.diseaseencefalopatíaSindrome desíndrome de SusacSurgeryAgudeza visualOphthalmologyOclusión de ramas arteriales retinianasOphthalmologyMedicineSensorineural hearing lossmedicine.symptommicroangiopatíabusinessSusac Syndrome
researchProduct

Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma

2015

medicine.medical_specialtyRetinal Neoplasmbusiness.industrymedicine.medical_treatmentRetinal detachmentGeneral MedicinePropranololmedicine.diseaseRefractoryOphthalmologyHemangioblastomaMedicineCombined Modality TherapyRanibizumabbusinessLaser coagulationmedicine.drugArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct

Retinal vein occlusion: current treatment.

2010

Retinal vein occlusion (RVO) is a pathology noted for more than 150 years. Although a lot has been written on the matter, it is still a frequent condition with multifactorial etiopathogenesis with many unclear aspects. The RVO pathogenesis has varied systemic and local implications that make it difficult to elaborate treatment guidelines. The management of the patient with RVO is very complex and a multidisciplinary approach is required in order to identify and correct the associated risk factors. Laser therapy remains the gold standard in RVO, but only modest functional improvement has been shown in branch retinal occlusion forms. Multicenter studies of intravitreal drugs present them as a…

medicine.medical_specialtyRetinal VeinPegaptanibAngiogenesis Inhibitorschemistry.chemical_compoundCentral retinal vein occlusionOcclusionRetinal Vein OcclusionmedicineHumansIntensive care medicineGlucocorticoidsLaser CoagulationVascular diseasebusiness.industryRetinalGeneral Medicinemedicine.diseaseCombined Modality TherapySensory SystemsSurgeryOphthalmologychemistryIntravitreal InjectionsRanibizumabbusinessRetinopathymedicine.drugOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
researchProduct

Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion.

2013

Macular edema is the leading cause of visual impairment in patients with retinal vein occlusion. Limited improvements may be obtained with laser photocoagulation or intravitreal triamcinolone. However, according to the data provided by randomized clinical trials, intravitreal injections of ranibizumab (Lucentis; Genentech, South San Francisco, CA) constitute a new effective and safe option for the management of these vision-threatening diseases. The aim of the present review is to summarize the clinical evidence of ranibizumab for macular edema due to retinal vein occlusions.

medicine.medical_specialtyRetinal Veingenetic structuresReviewlaw.inventionRandomized controlled triallcsh:OphthalmologylawOphthalmologyOcclusionMedicineIn patientranibizumabMacular edemaIntravitreal triamcinolonemacular edemabusiness.industrymedicine.diseaseVEGFeye diseasesantiangiogenic therapylcsh:RE1-994retinal vein occlusionRetinal vein occlusionsRanibizumabbusinessBiomedical engineeringmedicine.drugOphthalmology and eye diseases
researchProduct

Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation

2012

Purpose: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex® (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation. Methods: A 46-year-old female with 20/200 visual acuity was diagnosed with Coats’ disease with secondary retinal vasoproliferative tumor. An initial approach was performed with an intravitreal injection of the sustained-release dexamethasone implant Ozurdex. After reattachment of the retina, the telangiectatic vessels were treated with laser photocoagulation. Results: The patient’s visual acuity improved to 20/25 after the intravitreal Ozurdex. No further recurrences of exudation were evident through the 12-mon…

medicine.medical_specialtyRetinal vasoproliferative tumorVisual acuitychemistry.chemical_compoundRetinal telangiectasislcsh:OphthalmologyOphthalmologymedicineDexamethasone Intravitreal ImplantDexamethasone intravitreal implant (Ozurdex®)Coats' diseaseCoats’ diseaseDexamethasoneRetinabusiness.industryRetinalmedicine.diseaseSurgeryOphthalmologymedicine.anatomical_structurechemistrylcsh:RE1-994Published: March 2012Retinal TelangiectasisImplantmedicine.symptombusinessmedicine.drugCase Reports in Ophthalmology
researchProduct

D2-dopamine receptor blockade modulates temporal resolution in goldfish.

2002

A possible effect of dopamine on the temporal resolution of goldfish was investigated in a behavioral, two-alternative, forced-choice procedure. Flicker fusion frequency (FFF) was measured before and after bilateral intravitreal injections of D1- or D2-dopamine receptor (D1-/D2-R) antagonists, or after depletion of retinal dopamine by bilateral intravitreal injections of the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA). Prior to drug injections, fish achieved FFFs of 33–39 Hz. A D1-R antagonist, SCH 23390, reduced FFF by about 12% (P > 0.1), whereas a D2 antagonist, sulpiride, reduced the relative FFF by 25% (P < 0.03). Depletion of retinal dopamine with 6-OHDA induced a gradual…

medicine.medical_specialtySerotoninTime FactorsTyrosine 3-MonooxygenasePhysiologyBiologyChoice BehaviorRetinaFlicker Fusionchemistry.chemical_compoundAdrenergic AgentsDopamineInternal medicineGoldfishmedicineNeurotoxinAnimalsOxidopamineSCH-23390Behavior AnimalAdaptation OcularReceptors Dopamine D2DopaminergicAntagonistRetinalBenzazepinesImmunohistochemistrySensory SystemsDopamine D2 Receptor AntagonistsEndocrinologychemistryDopamine receptorConditioning OperantDopamine AntagonistsSulpirideSulpiridemedicine.drugVisual neuroscience
researchProduct